Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biosimilar”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06285019
What this trial is testing

Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 65
Large-scale testing (Phase 3)Active Not RecruitingNCT06348199
What this trial is testing

Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IV
Samsung Bioepis Co., Ltd. 555
Not applicableStudy completedNCT06313268
What this trial is testing

Safety of Effivia®, a Bevacizumab Biosimilar

Who this might be right for
Metastatic Colorectal CancerMetastatic Cervical CancerNon Squamous Non Small Cell Lung Cancer
Laboratorios Liomont 83
Early research (Phase 1)Study completedNCT04772274
What this trial is testing

Compare SB17 (Proposed Ustekinumab Biosimilar) to European Union (EU) Sourced Stelara and United States of America (US) Sourced Stelara in Healthy Subjects

Who this might be right for
Healthy
Samsung Bioepis Co., Ltd. 201
Large-scale testing (Phase 3)Study completedNCT05427305
What this trial is testing

TAB008 Compared to Avastin® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Efficacy
BioDlink Biopharm Co., Ltd. 549
Not applicableStudy completedNCT03323541
What this trial is testing

Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure

Who this might be right for
Multiple MyelomaNon-hodgkin LymphomaHodgkin Lymphoma
University Hospital, Brest 62
Large-scale testing (Phase 3)Study completedNCT02947438
What this trial is testing

Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)

Who this might be right for
Renal Anemia
Shenyang Sunshine Pharmaceutical Co., LTD. 207
Large-scale testing (Phase 3)Study completedNCT01895309
What this trial is testing

A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Who this might be right for
Rheumatoid Arthritis
Samsung Bioepis Co., Ltd. 596
Not applicableEnded earlyNCT02771795
What this trial is testing

A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC

Who this might be right for
Breast Neoplasms
Samsung Bioepis Co., Ltd. 538
Not applicableActive Not RecruitingNCT07235644
What this trial is testing

Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis

Who this might be right for
MS (Multiple Sclerosis)Multiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (Relapsing Remitting)
Uppsala University 184
Early research (Phase 1)Not Yet RecruitingNCT07581509
What this trial is testing

Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma

Who this might be right for
Adult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings)
Biocon Biologics UK PLC 138
Early research (Phase 1)Study completedNCT04238663
What this trial is testing

Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers

Who this might be right for
Healthy Volunteers
mAbxience Research S.L. 115
Post-approval studies (Phase 4)Ended earlyNCT04131322
What this trial is testing

Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.

Who this might be right for
Crohn DiseaseUlcerative Colitis
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 24
Testing effectiveness (Phase 2)UnknownNCT05029973
What this trial is testing

HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableStudy completedNCT03885037
What this trial is testing

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Who this might be right for
Rheumatoid Arthritis
Pfizer 77
Large-scale testing (Phase 3)Study completedNCT01936181
What this trial is testing

A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Who this might be right for
Rheumatoid Arthritis
Samsung Bioepis Co., Ltd. 584
Early research (Phase 1)Study completedNCT04183192
What this trial is testing

Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists

Who this might be right for
Healthy SubjectsPharmacokineticsPharmacodynamics
Food and Drug Administration (FDA) 72
Early research (Phase 1)Study completedNCT02631928
What this trial is testing

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III

Who this might be right for
Diabetes Mellitus
Julphar Gulf Pharmaceutical Industries 73